The medical community is experiencing a paradigm shift in thrombotic disorder management, with unprecedented attention being directed toward hypercoagulability conditions. This evolving landscape presents both challenges and opportunities as healthcare systems worldwide grapple with increasing patient populations requiring specialized anticoagulation therapy. The Clinical...